Drug eluting stents in the infrainguinal circulation

Techniques in Vascular and Interventional Radiology

Volumn 7, Issue 1, 2004, Pages 28-32

  Machan, Lindsay ^a,b  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; BATIMASTAT; CORTICOSTEROID; DACTINOMYCIN; ESTRADIOL; EVEROLIMUS; HEPARIN; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; MYCOPHENOLIC ACID; PACLITAXEL; PROTEIN TYROSINE KINASE INHIBITOR; RAPAMYCIN; TACROLIMUS; TRANILAST; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COATING; DRUG EFFECT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; FEMORAL ARTERY; FEMORAL ARTERY FLOW; HUMAN; MATERIAL COATING; PERIPHERAL CIRCULATION; POPLITEAL ARTERY; PROSPECTIVE STUDY; RANDOMIZATION; RESTENOSIS; TREATMENT OUTCOME; VALIDATION PROCESS; ANIMAL; HYPERPLASIA; INTIMA; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RADIOGRAPHY; RECURRENT DISEASE; REVIEW; STENT; VASCULAR PATENCY;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; FEMORAL ARTERY; HUMANS; HYPERPLASIA; PACLITAXEL; POPLITEAL ARTERY; RECURRENCE; SIROLIMUS; STENTS; TUNICA INTIMA; VASCULAR PATENCY;

EID: 2642510745     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tvir.2004.01.004     Document Type: Article

References (18)

1. Management of Peripheral Arterial Disease (PAD). TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 31:2003;S103-S108
2. Jamsen T.S., Manninen H.I., Jaakkola P.A., et al. Long-term outcome of patients with claudication after balloon angioplasty of the femoropopliteal arteries. Radiology. 225:2002;345-352
3. Jahnke T., Voshage G., Muller-Hulsbeck S., et al. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. JVIR. 13:2002;257-266
4. Mewisson M.W. Nitinol Stents in the Femoropopliteal Arterial Segment. Endovascular Today. 2:2003;29-34
5. Virmani R., Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol. 10:1999;499-506
6. Sousa J.E., Serruys P.W., Costa M.A. New frontiers in cardiology: drug-eluting stents: Part I. Circulation. 107:2003;2274-2279
7. Sousa J.E., Serruys P.W., Costa M.A. New frontiers in cardiology: drug-eluting stents: Part II. Circulation. 107:2003;2383-2389
8. Marx S.Q., Marks A.R. Bench to bedside the development of rapamycin and its application to stent restenosis. Circulation. 104:2001;852-855
9. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 349:2003;1315-1323
10. Signore P., Machan L.S., Jackson J., et al. Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J Vasc Interv Radiol. 12:2001;79-88
11. Hong M.K., Mintz G.S., Lee C.W., et al. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries A serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation. 107:2003;517-520
12. Grube E., Bullesfeld L. experience with paclitaxel-coated stents. J Interv Cardiol. 15:2002;471-475
13. Stone G.W. Taxus IV Results. Presented at TCT. 2003;. Annual Meeting, Washington, DC
14. Serruys P.W., Foley D.P., Kirkeeide R.L., et al. Restenosis revisited Insights provided by quantitative coronary angiography. Am Heart J. 126:1993;1243-1267
15. Duda S.H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease Six-month results. Circulation. 106:2002;1505-1509
16. Duda S.H. The SIROCCO trial. Presented at TCT. 2003;. Annual Meeting, Washington, DC
17. Faglia E., Mantero M., Caminiti M., et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med. 52:2002;225-232
18. Schmidt A., Ropers S., Braunlich S., et al. Drug-Eluting Stents for the Treatment of Obstructive Disease in Infrapopliteal Arteries. Poster presentation #362 at TCT. 2003;. Annual Meeting, Washington, DC